Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Pedestrian Injured in Hit and Run Crash on Wilmington Avenue


Vehicle Hits Person in Los Angeles Accident

Los Angeles, CA (April 13, 2020) – A pedestrian was injured in a hit and run crash in Los Angeles. The accident occurred on the evening of April 13 on Wilmington Avenue.

A vehicle hit a pedestrian at 11914 Wilmington Avenue. The victim was injured in the crash. The driver fled the accident scene. 

#Los Angeles 

#90059


December 12, 2019

Man Killed in Train Crash at Farmdale Avenue and West Exposition Boulevard

Victim Falls Onto Tracks in Fatal Los Angeles Accident...


December 24, 2019

1 Injured in Crash at Lankershim Boulevard and Sherman Way

Big Rig Crashes Into Liquor Store in North Hollywood Accident...


May 19, 2020

Luke Mancebo Killed in Crash at Bradbury and East Clausen Roads

Motorcycle, Semi Truck Collide in Fatal Delhi Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.